|
Age in years
|
|
•18–45
|
293 (4%)
|
278 (4%)
|
15 (3%)
|
|
•46–64
|
2187 (28%)
|
2063 (28%)
|
124 (24%)
|
|
•65 or older
|
5294 (68%)
|
4913 (68%)
|
381 (73%)
|
|
Gender
|
|
•Male
|
5596 (72%)
|
5244 (72%)
|
352 (68%)
|
|
•Female
|
2178 (28%)
|
2010 (28%)
|
168 (32%)
|
|
Surgery type
|
|
•Coronary artery bypass graft (CABG)
|
3963 (51%)
|
3762 (52%)
|
201 (38%)
|
|
•Valve replacement/repair
|
2363 (30%)
|
2224 (31%)
|
139 (27%)
|
|
•Aortic procedure
|
160 (2%)
|
136 (2%)
|
24 (5%)
|
|
•Multiple procedures
|
1288 (17%)
|
1132 (16%)
|
156 (30%)
|
|
Cardiopulmonary bypass
|
|
•Yes
|
6447 (83%)
|
6012 (83%)
|
435 (84%)
|
|
•No
|
1327 (17%)
|
1242 (17%)
|
85 (16%)
|
|
Admission type
|
|
•Elective
|
5400 (69%)
|
5099 (70%)
|
301 (58%)
|
|
•Non-elective/emergency
|
917 (12%)
|
831 (11%)
|
86 (17%)
|
|
•Transferred from another hospital
|
1457 (19%)
|
1324 (18%)
|
133 (26%)
|
|
Health conditions†
|
|
•Myocardial infarction
|
1819 (23%)
|
1679 (23%)
|
140 (27%)
|
|
•Congestive heart failure
|
1872 (24%)
|
1707 (24%)
|
165 (32%)
|
|
•Cerebrovascular disease
|
456 (6%)
|
419 (6%)
|
37 (7%)
|
|
•Peripheral vascular disease
|
1431 (18%)
|
1287 (18%)
|
144 (28%)
|
|
•Diabetes
|
1951 (25%)
|
1842 (25%)
|
109 (21%)
|
|
•Chronic pulmonary disease
|
1559 (20%)
|
1463 (20%)
|
96 (18%)
|
|
•Renal disease
|
1003 (13%)
|
902 (12%)
|
101 (19%)
|
|
•Anemia
|
287 (4%)
|
265 (4%)
|
22 (4%)
|
|
Medication use†
|
|
•Antiplatelet drugs
|
4681 (60%)
|
4382 (60%)
|
299 (58%)
|
|
•Oral anticoagulant drugs
|
1001 (13%)
|
936 (13%)
|
65 (13%)
|
|
•Non-steroidal anti-inflammatory drugs (NSAIDs)
|
448 (6%)
|
428 (6%)
|
20 (4%)
|
|
•Selective serotonin reuptake inhibitors (SSRIs)
|
588 (8%)
|
554 (8%)
|
34 (7%)
|
|
•Serotonin-norepinephrine reuptake inhibitors (SNRIs)
|
94 (1%)
|
89 (1%)
|
5 (1%)
|
|
Healthcare utilization†
|
|
•Hospitalization
|
2968 (38%)
|
2725 (38%)
|
243 (47%)
|
|
• ≥ 11 primary care encounters
|
3779 (49%)
|
3548 (49%)
|
231 (44%)
|
|
• ≥ 6 distinct prescription medications
|
2319 (30%)
|
2157 (30%)
|
162 (31%)
|
